Home / Brands / SSM Health Care St. Louis
SSM Health Care St. Louis Recalls
14 recalls on record · January 3, 2018 to April 10, 2024 · Drugs
Recalls by year
18
21
23
24
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
April 10, 2024DrugsFDA
SSM Health Care St. Louis DBA SSM St. Clare Health Center recalls FentaNYL citrate, 10 mcg in 0.9% Sodium Chloride 1 mL Vial (10 mcg/mL), 1.5 mL Total Volume per Vial, Intravenous, Rx On
Hazard: Lack of Assurance of Sterility: Firm did not perform process validation.
April 10, 2024DrugsFDA
SSM Health Care St. Louis DBA SSM St. Clare Health Center recalls Phenylephrine HCl, 1000 mcg/10 mL, 10 mL Total Volume per syringe, Intravenous, Rx Only, Hospital/Office Use Only, This
Hazard: Lack of Assurance of Sterility: Firm did not perform process validation.
June 7, 2023DrugsFDA
SSM Health Care St. Louis DBA SSM St. Clare Health Center recalls HYDROmorphone HCl 10 mg in 0.9% Sodium Chloridge, 50 mL syringe (0.2 mg/mL), Rx Only, SSM Health Care Corporation Outsou
Hazard: CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
October 20, 2021DrugsFDA
SSM Health Care St. Louis DBA SSM St. Clare Health Center recalls Potassium Chloride 40 mEq in 0.9% Sodium Chloride 270 mL NS, 250 mL bag, Rx Only, SSM Health Care Corporation, 1015 Bowl
Hazard: Lack of Assurance of Sterility
January 3, 2018DrugsFDA
SSM Health Care St. Louis DBA SSM St. Clare Health Center recalls Succinylcholine chloride 100 mg in 5 mL syringe, Concentration: 20 mg/mL. This is a compounded injectable drug; Rx only
Hazard: Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.
January 3, 2018DrugsFDA
SSM Health Care St. Louis DBA SSM St. Clare Health Center recalls Phenylephrine 1000 mcg in 0.9% Sodium Chloride 10 mL, 10 mL syringe, Concentration: 100 mcg/mL. This is a compounded in
Hazard: Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.
January 3, 2018DrugsFDA
SSM Health Care St. Louis DBA SSM St. Clare Health Center recalls Oxytocin 30 units in 0.9% Sodium Chloride 500 mL, 500 mL IV Bag, Concentration: 0.06 units/mL. This is a compounded inj
Hazard: Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.
January 3, 2018DrugsFDA
SSM Health Care St. Louis DBA SSM St. Clare Health Center recalls Norepinephrine 8 mg in dextrose 5% 250 mL, 250mL IV Bag, Concentration: 0.032 mg/mL, This is a compounded injectable dru
Hazard: Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.
January 3, 2018DrugsFDA
SSM Health Care St. Louis DBA SSM St. Clare Health Center recalls Neostigmine Methylsulfate 5 mg/5 mL, 5 mL Syringe, Concentration: 1 mg/mL. This is a compounded injectable drug; Rx onl
Hazard: Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.
January 3, 2018DrugsFDA
SSM Health Care St. Louis DBA SSM St. Clare Health Center recalls Morphine 50 mg in 0.9% Sodium Chloride 5 mL PCA, 50 mL Cartridge, Concentration: 1 mg/mL, This is a compounded injectabl
Hazard: Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.
January 3, 2018DrugsFDA
SSM Health Care St. Louis DBA SSM St. Clare Health Center recalls HYDROmorphone 10 mg in 0.9% Sodium Chloride 50 mL PCA, 50 mL Cartridge, Concentration: 0.2 mg/mL., This is a compounded
Hazard: Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.
January 3, 2018DrugsFDA
SSM Health Care St. Louis DBA SSM St. Clare Health Center recalls Fentanyl 2 mcg/mL and ropivacaine 0.2% in 0.9% Sodium Chloride 150 mL, 150 mL bag, This is a compounded injectable drug;
Hazard: Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.
January 3, 2018DrugsFDA
SSM Health Care St. Louis DBA SSM St. Clare Health Center recalls Amiodarone 900 mg in dextrose 5% 500 mL, 500 mL bag, Concentration: 1.8 mg/mL, This is a compounded injectable drug; Rx
Hazard: Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.
January 3, 2018DrugsFDA
SSM Health Care St. Louis DBA SSM St. Clare Health Center recalls Fentanyl 10 mcg in 0.9% Sodium Chloride 1 mL, 1 mL Vial, Concentration: 10 mcg/mL, This is a compounded injectable drug;
Hazard: Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.